ArticleAsian journal of pharmaceutical sciences2022

Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapy.

Yang Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.